| P2093 | author name string | Saud Al Sifri | |
| | Kashif Rizvi | |
| P2860 | cites work | Review of diabetes management and guidelines during Ramadan. | Q51402955 |
| | A comparison of glycemic effects of glimepiride, repaglinide, and insulin glargine in type 2 diabetes mellitus during Ramadan fasting. | Q51495383 |
| | A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. | Q51527160 |
| | Clinical and metabolic effects of fasting in 41 type 2 diabetic patients during Ramadan. | Q51567035 |
| | Diabetes care in Ramadan: An exemplar of person centered care | Q85217927 |
| | Safety and efficacy of gliclazide as treatment for type 2 diabetes: a systematic review and meta-analysis of randomized trials | Q27022613 |
| | Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes | Q28254549 |
| | A double-blind, randomized trial, including frequent patient-physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study | Q33710159 |
| | Recommendations for management of diabetes during Ramadan: update 2010. | Q34016169 |
| | Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management | Q34425731 |
| | The effect of vildagliptin relative to sulphonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: the VIRTUE study | Q34502809 |
| | GLP-1 receptor agonists vs. DPP-4 inhibitors for type 2 diabetes: is one approach more successful or preferable than the other? | Q34547492 |
| | Physiological and chronobiological changes during Ramadan intermittent fasting | Q34551423 |
| | Evaluating the Effect of Ramadan Fasting on Muslim Patients with Diabetes in relation to Use of Medication and Lifestyle Patterns: A Prospective Study | Q34574328 |
| | 1,5-anhydroglucitol (GlycoMark) as a marker of short-term glycemic control and glycemic excursions | Q34726941 |
| | Diabetes and Ramadan: an update on use of glycemic therapies during fasting | Q35165826 |
| | Muslims with non-insulin dependent diabetes fasting during Ramadan: treatment with glibenclamide | Q35189210 |
| | Ramadan and diabetes: As-Saum (The fasting). | Q35352472 |
| | The incidence of hypoglycaemia in Muslim patients with type 2 diabetes treated with sitagliptin or a sulphonylurea during Ramadan: a randomised trial | Q35659489 |
| | Impact of an individualized type 2 diabetes education program on clinical outcomes during Ramadan | Q35768892 |
| | Recommendations for management of diabetes during Ramadan: update 2015. | Q35768907 |
| | Drug intake during Ramadan | Q35905871 |
| | Pharmacological approaches to the management of type 2 diabetes in fasting adults during Ramadan | Q35997284 |
| | Role of oral hypoglycemic agents in the management of type 2 diabetes mellitus during Ramadan. | Q36107741 |
| | Diabetic emergencies including hypoglycemia during Ramadan | Q36107751 |
| | A prospective assessment of dietary patterns in Muslim subjects with type 2 diabetes who undertake fasting during Ramadan | Q36107784 |
| | Recommendations for management of diabetes during Ramadan | Q36241120 |
| | Diabetes and Ramadan: review of the literature | Q36463791 |
| | Vildagliptin vs sulfonylurea in Indian Muslim diabetes patients fasting during Ramadan | Q37417767 |
| | Experience with DPP-4 inhibitors in the management of patients with type 2 diabetes fasting during Ramadan | Q37427512 |
| | Experience with Vildagliptin in Type 2 Diabetic Patients Fasting During Ramadan in France: Insights from the VERDI Study | Q37468458 |
| | Implementation of Ramadan-specific diabetes management recommendations: a multi-centered prospective study from Pakistan | Q37609285 |
| | Statement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control | Q37621774 |
| | Glycemic effects of vildagliptin in patients with type 2 diabetes before, during and after the period of fasting in Ramadan | Q37679806 |
| | 1,5-Anhydroglucitol in diabetes mellitus | Q38030840 |
| | Dietary patterns and glycemic control and compliance to dietary advice among fasting patients with diabetes during Ramadan | Q38190047 |
| | Diabetes during Ramadan: underestimated, under-investigated, needs more attention. | Q38285848 |
| | Safety and effectiveness of non-insulin glucose-lowering agents in the treatment of people with type 2 diabetes who observe Ramadan: a systematic review and meta-analysis. | Q38380289 |
| | The effects of long term fasting in Ramadan on glucose regulation in type 2 diabetes mellitus | Q38424206 |
| | Fasting during Ramadan: efficacy, safety, and patient acceptability of vildagliptin in diabetic patients | Q38452890 |
| | South Asian Consensus Guideline: Use of GLP-1 analogue therapy in diabetes during Ramadan | Q38460116 |
| | Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during Ramadan | Q38484650 |
| | Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approach | Q38500160 |
| | Is Ramadan fasting safe in type 2 diabetic patients in view of the lack of significant effect of fasting on clinical and biochemical parameters, blood pressure, and glycemic control? | Q39197741 |
| | Attitudinal determinants of fasting in type 2 diabetes mellitus patients during Ramadan. | Q40029254 |
| | Fructosamine is a risk factor for myocardial infarction and all-cause mortality - Longitudinal experience from the AMORIS cohort | Q41462404 |
| | Multi-country retrospective observational study of the management and outcomes of patients with Type 2 diabetes during Ramadan in 2010 (CREED). | Q41592692 |
| | Fasting of Ramadan in peoples with diabetes in Benghazi, Libya: an exploratory study | Q41874346 |
| | Ramadan fasting: a study of changes in glucose profiles among patients with diabetes using continuous glucose monitoring | Q42539609 |
| | Practical Management of Diabetes during Ramadan Fast | Q42718139 |
| | Diabetes and fasting during Ramadan | Q42861741 |
| | Maintenance of glycaemic control with the evening administration of a long acting sulphonylurea in male type 2 diabetic patients undertaking the Ramadan fast | Q43067913 |
| | Vildagliptin therapy and hypoglycaemia in Muslim type 2 diabetes patients during Ramadan | Q43292520 |
| | Comparison of the dipeptidyl peptidase-4 inhibitor vildagliptin and the sulphonylurea gliclazide in combination with metformin, in Muslim patients with type 2 diabetes mellitus fasting during Ramadan: results of the VECTOR study | Q43406843 |
| | Glycaemic trend during Ramadan in fasting diabetic subjects: a study from Pakistan. | Q44058303 |
| | Repaglinide versus glibenclamide treatment of Type 2 diabetes during Ramadan fasting | Q44088446 |
| | A randomized controlled trial comparing the GLP-1 receptor agonist liraglutide to a sulphonylurea as add on to metformin in patients with established type 2 diabetes during Ramadan: the Treat 4 Ramadan Trial | Q44197835 |
| | Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study. | Q44667617 |
| | The effects of diet, sulfonylurea, and Repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan | Q45097303 |
| | The efficacy and safety of glimepiride in the management of type 2 diabetes in Muslim patients during Ramadan | Q45242374 |
| | An open label comparative study of glimepiride versus repaglinide in type 2 diabetes mellitus Muslim subjects during the month of Ramadan. | Q47205397 |
| | The impact of fasting during Ramadan on the glycemic control of patients with type 2 diabetes mellitus | Q47807165 |
| | Effectiveness of contextual education for self-management in Thai Muslims with type 2 diabetes mellitus during Ramadan. | Q48055875 |
| | Managing diabetes during the Muslim fasting month of Ramadan. | Q48369261 |
| | Ramadan Prospective Diabetes Study: the role of drug dosage and timing alteration, active glucose monitoring and patient education | Q48442573 |
| | The effects of fasting during Ramadan on glycemic excursions detected by continuous glucose monitoring system (CGMS) in patients with type 2 diabetes | Q48473588 |
| | Summer-winter switching of the Ramadan fasts in people with diabetes living in temperate regions | Q48552387 |
| | Effect of Ramadan fasting on glycemic control in patients with Type 2 diabetes | Q48573121 |
| | Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study | Q48687166 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | knowledge gap hypothesis | Q1481327 |
| | knowledge gap | Q122958306 |
| P304 | page(s) | 221-40 | |
| P577 | publication date | 2016-06-01 | |
| P1433 | published in | Diabetes Therapy | Q26853803 |
| P1476 | title | Filling the Knowledge Gap in Diabetes Management During Ramadan: the Evolving Role of Trial Evidence | |
| P478 | volume | 7 | |